ICM
LIVN icon

Invenomic Capital Management’s LivaNova LIVN Stock Holding History

Invenomic Capital Management’s Portfolio LIVN Stock Details LIVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,633
Closed -$174K – 141
2020
Q4 		$174K Buy
+2,633
New +$146K 0.04% 129

Other funds holding LIVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $3.12B AUM 53.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Invenomic Capital Management's LIVN Position: Q1 2021 in Review

Invenomic Capital Management sold out of LivaNova (LIVN) in Q1 2021, closing a stake of 2,633 shares — an estimated $174K sold.

Invenomic Capital Management first reported a position in LIVN in Q4 2020 and held it in 1 quarter. The position peaked at $174K in Q4 2020. 203 funds tracked by Wall St. Rank hold LIVN as of Q1 2021.

  • Invenomic Capital Management reported no remaining LivaNova position as of Q1 2021 after selling out during the quarter.
  • Invenomic Capital Management sold 2,633 LivaNova shares in Q1 2021, an estimated $174K.
  • Invenomic Capital Management first reported a position in LivaNova in Q4 2020 and held it in 1 quarter.
  • Invenomic Capital Management's LivaNova position peaked at $174K in Q4 2020.
  • 203 funds tracked by Wall St. Rank held LivaNova as of Q1 2021.

Based on Invenomic Capital Management's 13F filing for Q1 2021, filed 13 May 2021.